Clinical Study on Tiaogeng Prescription Intervention in Early Menopausal Women with aMCI

Not Applicable

• Conditions: aMCI

• Registration Number: ITMCTR2000003684
• Lead Sponsor: onghua Hospital, Shanghai University of Traditional Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: Female
• Target Recruitment: Not specified

Inclusion Criteria

(1) 40~60 years old (including 60 years old);
(2) Meet the diagnostic criteria of western medicine for menopausal syndrome and MCI;
(3) Patients with deficiency of kidney yin and deficiency of both kidney yin and yang that meet the TCM syndrome differentiation standards;
(4) 1 year (5) Those who voluntarily participated in this study.

Exclusion Criteria

(1) Patients with severe heart, liver, kidney, brain and other organic diseases and severe physical diseases and malignant tumors;
(2) Patients with active thyroid disease;
(3) Those who are allergic to known pharmaceutical ingredients;
(4) Patients with severe depression (Beck Depression Inventory BDI-II score> 28 points);
(5) Exclude people with cognitive dysfunction caused by trauma, brain tumors and surgery;
(6) Alcohol and drug abusers;
(7) Patients who have used banned drugs in the past 3 months or participated in other clinical trials;
(8) Patients with folic acid and vitamin B12 deficiency.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Auditory Vocabulary Learning Test Huashan Version;MoCA Scale;Wechsler Memory Scale;

Secondary Outcome Measures

Name	Time	Method
Evaluation of menopausal symptoms;Serum sex hormone assessment;Sleep quality assessment;Metabolic index evaluation;TCM symptom assessment;